MIR-19

N/A

Report date: 2023/03/27 20:00:44

Base Information

Drug NameMIR-19
Drug Alias Namecomplex of siRNAMIR-19
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionSARS-CoV-2-3C-like-proteinase inhibitors
TargetsSARS-CoV-2-3C-like-proteinase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesSt. Petersburg Scientific Research Institute of Vaccines and Sera
China Registration ClassN/A

Develop Information

Active CompaniesInstitute of Immunology Federal Medical-Biological AgencySt. Petersburg Scientific Research Institute of Vaccines and Sera
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A